Search PubMedSearch

PubMed · 8735569

Catecholamines decrease lymphocyte adhesion to cytokine-activated endothelial cells.

Abstract

Numerous studies have shown that catecholamines can modulate lymphocyte migration. This effect may be mediated in part by modulation of lymphocyte-endothelial cell interactions, which is dependent on adhesion molecules expressed on both of these cells. Our results show that catecholamines decreased T-cell binding to IL-1 activated endothelial cells in vitro. The decrease in adhesion was not mediated by a change in adhesion molecule expression as LFA-1 and VLA-4 expression on T-cells and ICAM-1 and VCAM-1 expression on endothelial cells were not changed by catecholamine stimulation. T-cells flatten and enlarge the area of surface contact as they adhere to endothelial cells. Image analysis of the number of T-cells bound and the amount of cell spreading over several time points suggests that catecholamines alter the kinetics of T-cell-endothelial cell adhesion. These results support the hypothesis that catecholamines can alter lymphocyte-endothelial interactions in vivo, which in turn would affect lymphocyte migration.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S L Carlson, D J Beiting, C A Kiani, K M Abell, J P McGillis. 1996. Catecholamines decrease lymphocyte adhesion to cytokine-activated endothelial cells.. https://doi.org/10.1006/brbi.1996.0005

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Erythrocyte superoxide dismutase activity in patients with digest cancer: adjuvant diagnosis test.

Previous studies showed that a common feature of tumor cells is their low of superoxide dismutase (SOD) activity. Our research proved that carcinogenic substances reduce erythrocyte SOD activity, while anticarcinogenic ones increase it and that in vitro SOD assessments revealed a direct mechanism of action. In this paper we determined erythrocyte SOD activity in patients with digestive and extra-digestive cancers. We studied eight groups of patients with five different forms of cancer (histopathologically confirmed) and three groups of volunteers. Group 1 (n = 86), patients with esophageal cancer; Group 2 (n = 94), patients with gastric cancer; Group 3 (n = 79), patients with colorectal cancer; Group 4 (n = 71), patients with hepatic cancer; Group 5 (n = 73), patients with pancreatic cancer; Group 6 (n = 85), patients with with other diseases, but of the same organs; Group 7 (n = 97), healthy volunteers; Group 8 (n = 91), hypertensive patients. We determined the erythrocyte SOD activity using the catecholamine oxidation method. Erythrocyte SOD from the first 5 groups had a mean value of 1.91 +/- 0.78 EU as compared with Group 6 which presented an activity of 6.08 +/- 1.02 (P < 0.001) and Group7 in which the activity was 6.54 +/- 1.23 (P < 0, 001). Erythrocyte SOD activity is significantly reduced (by 2-3 fold) in all groups of cancer patients studied. Being accessible, simple and rapid, erythrocyte SOD activity determination could constitute an adjuvant test in diagnosis of these types of cancer. Taking into account our previous results which prove that carcinogenic substances inhibit SOD activity by a direct mechanism, we suggest that further research is required in this exciting field.

Catecholamines

Study of catecholamines in patient urine samples by capillary electrophoresis.

Capillary zone electrophoresis with photodiode array detection at 220 nm was used for analysis of catechol compounds in human urine. The method was optimized with reference compounds 3,4-dihydroxybenzylamine, adrenaline, noradrenaline, normetanephrine, dopamine, dopac (homogensitic acid), methanephrine, vanillyl-mandelic acid, 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid and 3-methoxytyramic acid at pH 4.0 and 8.0 for their electrophoretic separation. The UV spectra of the catechols were detected at a concentration of 20 microM. Repeatability of the method calculated using the absolute migration times of the catechols was below 1.5% and using the peak areas below 5%. The patient samples were hydrolyzed by 0.5 M acid or base solutions. In the studies, a few patient samples were analyzed using 3,4-dihydroxybenzylamine as an internal standard. In the hydrolysis steps needed for their detection in urine, all the other catecholamines, except 5-HIAA, did not decompose to detectable species at 220 or 254 nm. The concentrations of the catecholamines observed in real samples were at nM levels.

Catecholamines

Electrochemical and esr spin trap studies of a new iron tetra-catecholamide complex.

A new siderophore, N5,N6-thiodipropanoyl-bis[N1,N10-bis(2,3-dihydroxy benzoyl-spermidine)]-Fe (III) complex or H2LFe has been synthesised. The reaction of the reduced form of this complex with dioxygen has been investigated through electrochemical study and revealed the formation of a new species assumed to be H2O2. This species has been confirmed by esr spectroscopy using the diamagnetic compound 5-deutero-2,2,5-trimethylpyrrolidine-1-hydroxyl as spin trap. The resulting persistent radical is 5-deutero-2,2,5-trimethylpyrrolidine-1-yloxy (aN = 16.58 G, aD = 3.49 G).

Catecholamines